Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial

Persson, F; Rossing, P; Vart, P; Chertow, GM; Hou, FF; Jongs, N; McMurray, JJV; Correa-Rotter, R; Bajaj, HS; Stefansson, BV; Toto, RD; Langkilde, AM; Wheeler, DC; Heerspink, HJL

Persson, F (corresponding author), Steno Diabet Ctr Copenhagen, Gentofte, Denmark.

DIABETES CARE, 2021; 44 (8): 1894

Abstract

OBJECTIVE The Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) study demonstrated risk reduction for kidney and c......

Full Text Link